Cargando…

Low thyroid function is associated with an increased risk of advanced fibrosis in patients with metabolic dysfunction-associated fatty liver disease

AIMS: Observational studies showed that low thyroid function may perturb liver function. We aimed to evaluate the association of low thyroid function with both metabolic dysfunction-associated fatty liver disease (MAFLD) and advanced hepatic fibrosis. METHODS: Participants who underwent abdominal ul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Hong, Li, Lili, Liu, Zhenqiu, Zhang, Pengyan, Wu, Sheng, Han, Xinyu, Chen, Xingdong, Suo, Chen, Cao, Liou, Zhang, Tiejun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814300/ https://www.ncbi.nlm.nih.gov/pubmed/36604612 http://dx.doi.org/10.1186/s12876-022-02612-3

Ejemplares similares

Investigating the Effect of Metabolic Phenotypes on Health Events in Alcoholic and Nonalcoholic Fatty Liver Disease
por: Fan, Hong, et al.
Publicado: (2023)

Investigating the Association Between Seven Sleep Traits and Nonalcoholic Fatty Liver Disease: Observational and Mendelian Randomization Study
por: Fan, Hong, et al.
Publicado: (2022)

Global trends in the incidence and mortality of esophageal cancer from 1990 to 2017
por: Fan, Jiahui, et al.
Publicado: (2020)

Alcohol consumption and hepatocellular carcinoma: novel insights from a prospective cohort study and nonlinear Mendelian randomization analysis
por: Liu, Zhenqiu, et al.
Publicado: (2022)

Changing trends in the disease burden of primary liver cancer caused by specific etiologies in China
por: Liu, Zhenqiu, et al.
Publicado: (2019)

Association Between Thyroid Hormone Levels and Advanced Liver Fibrosis in Patients with Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease
por: Du, Jing, et al.
Publicado: (2021)

Association of Metabolic Dysfunction-Associated Fatty Liver Disease With Left Ventricular Diastolic Function and Cardiac Morphology
por: Peng, Dandan, et al.
Publicado: (2022)

Global Burden and Trends in Incidence, Mortality, and Disability of Stomach Cancer From 1990 to 2017
por: Qin, Yuheng, et al.
Publicado: (2021)

Liver Fibrosis Scores and Coronary Artery Disease: Novel Findings in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease
por: Lu, Chuan, et al.
Publicado: (2023)

Extreme sampling design in genetic association mapping of quantitative trait loci using balanced and unbalanced case-control samples
por: Li, Yi, et al.
Publicado: (2019)

The trends and projections in the incidence and mortality of liver cancer in urban Shanghai: a population-based study from 1973 to 2020
por: Bai, Lei, et al.
Publicado: (2018)

Low–Normal Thyroid Function Is Not Associated with Either Non-Alcoholic Fatty Liver Disease or with Metabolic Dysfunction-Associated Fatty Liver Disease
por: Zuarth-Vázquez, Julia, et al.
Publicado: (2023)

The nonlinear relationship between thyroid function parameters and metabolic dysfunction-associated fatty liver disease
por: Hu, Yingying, et al.
Publicado: (2023)

Serum folate associated with nonalcoholic fatty liver disease and advanced hepatic fibrosis
por: Chen, Hao-Kai, et al.
Publicado: (2023)

Interaction of metabolic dysfunction‐associated fatty liver disease and nonalcoholic fatty liver disease with advanced fibrosis in the death and intubation of patients hospitalized with coronavirus disease 2019
por: Vázquez‐Medina, Martín Uriel, et al.
Publicado: (2022)

Changing epidemiological patterns of HIV and AIDS in China in the post-SARS era identified by the nationwide surveillance system
por: Liu, Zhenqiu, et al.
Publicado: (2018)

Increasing prevalence of NAFLD/NASH among children, adolescents and young adults from 1990 to 2017: a population-based observational study
por: Zhang, Xin, et al.
Publicado: (2021)

Validation of Non-invasive Fibrosis Scores for Predicting Advanced Fibrosis in Metabolic-associated Fatty Liver Disease
por: Chen, Xiaoning, et al.
Publicado: (2022)

Sequential algorithm to stratify liver fibrosis risk in overweight/obese metabolic dysfunction-associated fatty liver disease
por: Lee, Chi-Ho, et al.
Publicado: (2023)

The Role of Thyroid Hormones and Autoantibodies in Metabolic Dysfunction Associated Fatty Liver Disease: TgAb May Be a Potential Protective Factor
por: Zhang, Xiaofu, et al.
Publicado: (2020)

Metabolic Dysfunction-Associated Fatty Liver Disease Is Associated with the Risk of Incident Cardiovascular Disease: A Prospective Cohort Study in Xinjiang
por: Guo, Yanbo, et al.
Publicado: (2022)

Fatty liver is associated with significant liver inflammation and increases the burden of advanced fibrosis in chronic HBV infection
por: Dai, Yi-Ning, et al.
Publicado: (2023)

Impact of the new definition of metabolic dysfunction–associated fatty liver disease on detection of significant liver fibrosis in US adolescents
por: Ciardullo, Stefano, et al.
Publicado: (2022)

Fibrosis Burden of Missed and Added Populations According to the New Definition of Metabolic Dysfunction-Associated Fatty Liver
por: Park, Huiyul, et al.
Publicado: (2021)

Metabolic Dysfunction-associated Fatty Liver Disease is Associated with Greater Impairment of Lung Function than Nonalcoholic Fatty Liver Disease
por: Miao, Lei, et al.
Publicado: (2022)

Association of Esophageal Squamous Cell Carcinoma With the Interaction Between Poor Oral Health and Single Nucleotide Polymorphisms in Regulating Cell Cycles and Angiogenesis: A Case-Control Study in High-Incidence Chinese
por: Zhao, Renjia, et al.
Publicado: (2022)

BMI trajectory of rapid and excessive weight gain during adulthood is associated with bone loss: a cross-sectional study from NHANES 2005–2018
por: Wang, Jiacheng, et al.
Publicado: (2023)

Pancreatic β-Cell Dysfunction Is Associated with Nonalcoholic Fatty Liver Disease
por: Chen, Xu, et al.
Publicado: (2021)

High-Sensitive CRP Correlates With the Severity of Liver Steatosis and Fibrosis in Obese Patients With Metabolic Dysfunction Associated Fatty Liver Disease
por: Zhu, Cuiling, et al.
Publicado: (2022)

Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease
por: Salgado Alvarez, Giovanni Alejandro, et al.
Publicado: (2022)

Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management
por: Xu, Yanlan, et al.
Publicado: (2021)

The Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Peripheral Arterial Disease in the Chinese Population
por: Song, Xiao-Hui, et al.
Publicado: (2023)

Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
por: Han, A Lum
Publicado: (2022)

Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease
por: Lin, Huapeng, et al.
Publicado: (2021)

Metabolic dysfunction-associated fatty liver disease and cardiovascular disease: A meta-analysis
por: Wen, Wen, et al.
Publicado: (2022)

Association between Atrial Fibrillation and Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
por: Kang, Min Kyu, et al.
Publicado: (2020)

Association Between Sensitivity to Thyroid Hormones and Metabolic Dysfunction-Associated Fatty Liver Disease in Euthyroid Subjects: A Cross-Sectional Study
por: Liu, Huanxin, et al.
Publicado: (2023)

Association of Metabolic Dysfunction-Associated Fatty Liver Disease and Liver Stiffness With Bone Mineral Density in American Adults
por: Li, Hejun, et al.
Publicado: (2022)

The implication of neutrophil extracellular traps in nonalcoholic fatty liver disease
por: Fa, Pengyan, et al.
Publicado: (2023)

Serum Uric Acid but Not Ferritin Level Is Associated with Hepatic Fibrosis in Lean Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease: A Community-Based Study
por: Xie, Cheng-Han, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_odvtseg24lmb9cagspfhuhoddv